Previous 10 | Next 10 |
The letter did not identify any issues with the efficacy or safety data submitted in the application The U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) for the Biologics License Application (BLA) seeking accelerated approval of Daiichi Sankyo (TSE: 4...
2024-06-25 17:06:01 ET More on Merck Dividends And Innovation: Why Merck Is A Healthcare Stock Worth Buying Merck gets FDA approval for Capvaxive pneumonia vaccine (update) Merck's Keytruda gains approval for additional endometrial carcinoma indication Merck ...
Innovative technology represents a breakthrough scientific achievement for highly contagious respiratory disease Merck Animal Health, known as MSD Animal Health outside of the United States and Canada, a division of Merck & Co., Inc., Rahway, N.J., USA (NYSE:MRK), announced today th...
2024-06-25 12:54:41 ET Summary AstraZeneca is becoming a leader in the cancer therapeutics market, which is reflected in the growth of its share price. On June 25, 2024, Tagrisso, in combination with chemotherapy, was approved in Japan as the first-line treatment for people with N...
2024-06-23 12:49:01 ET More on the markets SPY: The Upside Is Likely Capped SPY: Rating Downgrade Due To Overvaluation Perfect Time For November Election Protection S&P posts three-week win streak, but momentum stalls after hitting 5,500 points mark ...
2024-06-23 11:13:33 ET Summary Since the publication of my last article, Pfizer has continued to surprise me pleasantly. In early May, Pfizer published financial results for the first quarter of 2024, which were enthusiastically received by Wall Street. On June 14, 2024, the c...
2024-06-21 10:22:22 ET More on S&P 500 Index: SP500: Why The Next Decade Might Underwhelm Investors After The Summit: U.S. Energy, Global Energy - Drivers And Opportunities Market Living On Borrowed Time Nasdaq, S&P, and Dow trade mixed while yields s...
2024-06-20 16:10:36 ET More on Esperion Therapeutics Buy Esperion Therapeutics Despite An Abiding Skepticism Weighing On The Stock Esperion's late stage trial of high cholesterol treatment met main goal Esperion Therapeutics beats top-line and bottom-line estimates; ...
2024-06-20 10:30:00 ET June 20, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform, releases an industry snapshot looking at the future treatment of solid cancer tumors, featuring Aethlon Medical, Inc. (Nasdaq:AEMD ), a medical therapeutic company f...
NORTHAMPTON, MA / ACCESSWIRE / June 20, 2024 / Building the workforce of tomorrow means investing in the students of today. That's why Merck has partnered with North Carolina Agricultural and Technical State University (N.C. A&T) - the largest historically Black college and university in the...
News, Short Squeeze, Breakout and More Instantly...
How one employee's upbringing and career journey have motivated her to fight inequities around the world NORTHAMPTON, MA / ACCESSWIRE / July 16, 2024 / For Priya Agrawal, health equity has been a lifelong concern and a guiding principle in the work she's done across industries. As a young...
Symposia will highlight work to overcome HIV-related stigma and discuss the evolving state of HIV treatment and prevention Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced upcoming data presentations and programming at the 25 th International ...
Acquisition strengthens and diversifies Merck’s pipeline with the addition of Restoret™, a novel late-phase candidate for diabetic macular edema and neovascular age-related macular degeneration, as well as preclinical candidates Merck (NYSE: MRK), known as MSD outside of t...